# American Express Co: financial statements, quarterly AXP · NYSE · CIK 4962 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/axp.md) · [Financials](/companies/axp/financials.md) · [Filings](/companies/axp/filings.md) · [Insiders](/companies/axp/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/axp/financials.md?period=annual). ## Income statement | Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $bn | [9.6 d](/filings/0000004962-26-000080.md) | [9.3](/filings/0000004962-25-000045.md) | [9.8](/filings/0000004962-25-000083.md) | [9.7](/filings/0000004962-25-000222.md) | [10.0 d](/filings/0000004962-26-000080.md) | [9.6](/filings/0000004962-26-000192.md) | [10.3](/filings/0000004962-26-000322.md) | [10.4](/filings/0000004962-26-000409.md) | [10.9 d](/filings/0000004962-26-000080.md) | [10.5](/filings/0000004962-26-000192.md) | [11.2](/filings/0000004962-26-000322.md) | [11.2](/filings/0000004962-26-000409.md) | | Operating income | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Interest expense | $bn | [1.9 d](/filings/0000004962-24-000013.md) | [2.0](/filings/0000004962-24-000031.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Income tax | $bn | [0.6 d](/filings/0000004962-26-000080.md) | [0.7](/filings/0000004962-25-000045.md) | [0.8](/filings/0000004962-25-000083.md) | [0.7](/filings/0000004962-25-000222.md) | [0.6 d](/filings/0000004962-26-000080.md) | [0.7](/filings/0000004962-26-000192.md) | [0.7](/filings/0000004962-26-000322.md) | [0.9](/filings/0000004962-26-000409.md) | [0.6 d](/filings/0000004962-26-000080.md) | [0.8](/filings/0000004962-26-000192.md) | [1.0](/filings/0000004962-26-000322.md) | [0.8](/filings/0000004962-26-000409.md) | | Net income | $bn | [1.9 d](/filings/0000004962-26-000080.md) | [2.4](/filings/0000004962-25-000045.md) | [3.0](/filings/0000004962-25-000083.md) | [2.5](/filings/0000004962-25-000222.md) | [2.2 d](/filings/0000004962-26-000080.md) | [2.6](/filings/0000004962-26-000192.md) | [2.9](/filings/0000004962-26-000322.md) | [2.9](/filings/0000004962-26-000409.md) | [2.5 d](/filings/0000004962-26-000080.md) | [3.0](/filings/0000004962-26-000192.md) | [3.1](/filings/0000004962-26-000322.md) | [3.7](/filings/0000004962-26-000409.md) | | Diluted EPS | $ per share | not reported | [3.33](/filings/0000004962-25-000045.md) | [4.15](/filings/0000004962-25-000083.md) | [3.49](/filings/0000004962-25-000222.md) | not reported | [3.64](/filings/0000004962-26-000192.md) | [4.08](/filings/0000004962-26-000322.md) | [4.14](/filings/0000004962-26-000409.md) | not reported | [4.28](/filings/0000004962-26-000192.md) | [4.53](/filings/0000004962-26-000322.md) | [5.42](/filings/0000004962-26-000409.md) | | Basic EPS | $ per share | not reported | [3.34](/filings/0000004962-25-000045.md) | [4.16](/filings/0000004962-25-000083.md) | [3.50](/filings/0000004962-25-000222.md) | not reported | [3.64](/filings/0000004962-26-000192.md) | [4.08](/filings/0000004962-26-000322.md) | [4.14](/filings/0000004962-26-000409.md) | not reported | [4.29](/filings/0000004962-26-000192.md) | [4.54](/filings/0000004962-26-000322.md) | [5.43](/filings/0000004962-26-000409.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Operating income: not reported - Interest expense: us-gaap:InterestExpense - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Total assets | $bn | [261](/filings/0000004962-26-000080.md) | [269](/filings/0000004962-25-000045.md) | [272](/filings/0000004962-25-000083.md) | [271](/filings/0000004962-25-000222.md) | [271](/filings/0000004962-26-000080.md) | [282](/filings/0000004962-26-000192.md) | [296](/filings/0000004962-26-000322.md) | [298](/filings/0000004962-26-000409.md) | [300](/filings/0000004962-26-000409.md) | [309](/filings/0000004962-26-000192.md) | [308](/filings/0000004962-26-000322.md) | [310](/filings/0000004962-26-000409.md) | | Total liabilities | $bn | [233](/filings/0000004962-25-000016.md) | [240](/filings/0000004962-24-000031.md) | [243](/filings/0000004962-24-000052.md) | [241](/filings/0000004962-24-000068.md) | [241](/filings/0000004962-26-000080.md) | [251](/filings/0000004962-25-000045.md) | [263](/filings/0000004962-25-000083.md) | [265](/filings/0000004962-25-000222.md) | [267](/filings/0000004962-26-000409.md) | [275](/filings/0000004962-26-000192.md) | [274](/filings/0000004962-26-000322.md) | [274](/filings/0000004962-26-000409.md) | | Long-term debt | $bn | [47.9](/filings/0000004962-25-000016.md) | [48.8](/filings/0000004962-24-000031.md) | [51.5](/filings/0000004962-24-000052.md) | [53.5](/filings/0000004962-24-000068.md) | [49.7](/filings/0000004962-26-000080.md) | [51.2](/filings/0000004962-25-000045.md) | [58.2](/filings/0000004962-25-000083.md) | [57.8](/filings/0000004962-25-000222.md) | [56.4](/filings/0000004962-26-000409.md) | [58.8](/filings/0000004962-26-000192.md) | [57.0](/filings/0000004962-26-000322.md) | [58.5](/filings/0000004962-26-000409.md) | | Short-term borrowings | $bn | [1.3](/filings/0000004962-25-000016.md) | [1.7](/filings/0000004962-24-000031.md) | [1.6](/filings/0000004962-24-000052.md) | [1.5](/filings/0000004962-24-000068.md) | [1.4](/filings/0000004962-26-000080.md) | [1.6](/filings/0000004962-25-000045.md) | [1.5](/filings/0000004962-25-000083.md) | [1.4](/filings/0000004962-25-000222.md) | [1.4](/filings/0000004962-26-000409.md) | [1.7](/filings/0000004962-26-000192.md) | [2.0](/filings/0000004962-26-000322.md) | [1.4](/filings/0000004962-26-000409.md) | | Shareholders' equity | $bn | [28.1](/filings/0000004962-26-000080.md) | [28.8](/filings/0000004962-25-000083.md) | [29.5](/filings/0000004962-25-000222.md) | [29.7](/filings/0000004962-25-000222.md) | [30.3](/filings/0000004962-26-000409.md) | [31.2](/filings/0000004962-26-000322.md) | [32.3](/filings/0000004962-26-000409.md) | [32.4](/filings/0000004962-26-000409.md) | [33.5](/filings/0000004962-26-000409.md) | [34.0](/filings/0000004962-26-000322.md) | [34.3](/filings/0000004962-26-000409.md) | [35.8](/filings/0000004962-26-000409.md) | - Cash and equivalents: not reported - Total assets: us-gaap:Assets - Total liabilities: us-gaap:Liabilities - Long-term debt: us-gaap:LongTermDebt - Short-term borrowings: us-gaap:ShortTermBorrowings - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [6,769 d](/filings/0000004962-26-000080.md) | [5,552](/filings/0000004962-25-000045.md) | [4,532 d](/filings/0000004962-25-000083.md) | [(1,812) d](/filings/0000004962-25-000222.md) | [5,778 d](/filings/0000004962-26-000080.md) | [4,764](/filings/0000004962-26-000192.md) | [4,364 d](/filings/0000004962-26-000322.md) | [6,233 d](/filings/0000004962-26-000409.md) | [3,067 d](/filings/0000004962-26-000080.md) | [3,804](/filings/0000004962-26-000192.md) | [5,371 d](/filings/0000004962-26-000322.md) | [5,384 d](/filings/0000004962-26-000409.md) | | Capital expenditure | $m | [426 d](/filings/0000004962-26-000080.md) | [396](/filings/0000004962-25-000045.md) | [565 d](/filings/0000004962-25-000083.md) | [455 d](/filings/0000004962-25-000222.md) | [495 d](/filings/0000004962-26-000080.md) | [430](/filings/0000004962-26-000192.md) | [619 d](/filings/0000004962-26-000322.md) | [654 d](/filings/0000004962-26-000409.md) | [722 d](/filings/0000004962-26-000080.md) | [1,149](/filings/0000004962-26-000192.md) | [898 d](/filings/0000004962-26-000322.md) | [947 d](/filings/0000004962-26-000409.md) | | Dividends paid | $m | [454 d](/filings/0000004962-26-000080.md) | [452](/filings/0000004962-25-000045.md) | [521 d](/filings/0000004962-25-000083.md) | [516 d](/filings/0000004962-25-000222.md) | [510 d](/filings/0000004962-26-000080.md) | [509](/filings/0000004962-26-000192.md) | [593 d](/filings/0000004962-26-000322.md) | [586 d](/filings/0000004962-26-000409.md) | [583 d](/filings/0000004962-26-000080.md) | [583](/filings/0000004962-26-000192.md) | [665 d](/filings/0000004962-26-000322.md) | [668 d](/filings/0000004962-26-000409.md) | | Share repurchases | $m | [901 d](/filings/0000004962-26-000080.md) | [1,292](/filings/0000004962-25-000045.md) | [1,762 d](/filings/0000004962-25-000083.md) | [1,935 d](/filings/0000004962-25-000222.md) | [1,031 d](/filings/0000004962-26-000080.md) | [1,208](/filings/0000004962-26-000192.md) | [1,356 d](/filings/0000004962-26-000322.md) | [2,351 d](/filings/0000004962-26-000409.md) | [899 d](/filings/0000004962-26-000080.md) | [1,911](/filings/0000004962-26-000192.md) | [2,304 d](/filings/0000004962-26-000322.md) | [1,590 d](/filings/0000004962-26-000409.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Dividends paid: us-gaap:PaymentsOfDividends - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [744](/filings/0000004962-24-000031.md) | [741](/filings/0000004962-24-000052.md) | [733](/filings/0000004962-24-000068.md) | [722](/filings/0000004962-25-000045.md) | [717](/filings/0000004962-25-000083.md) | [709](/filings/0000004962-25-000222.md) | [702](/filings/0000004962-26-000192.md) | [699](/filings/0000004962-26-000322.md) | [693](/filings/0000004962-26-000409.md) | [686](/filings/0000004962-26-000192.md) | [679](/filings/0000004962-26-000322.md) | [674](/filings/0000004962-26-000409.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 670,552,018 at 2026-10-15, from the cover of the [10-Q filed 2026-10-23](/filings/0000004962-26-000409.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:17 ET. No prices; not investment advice.